Johns Hopkins Medicine surgeons to receive $21.4 million to advance xenotransplantation research

Loading
64670login-checkJohns Hopkins Medicine surgeons to receive $21.4 million to advance xenotransplantation research

As part of the worldwide effort to facilitate a research and clinical pathway toward successful xenotransplantation -; the transplantation of living cells, tissues and organs from one species to another -; two Johns Hopkins Medicine surgeons, Kazuhiko Yamada, M.D., Ph.D., and Andrew Cameron, M.D., Ph.D., will receive a total of $21.4 million in funding over the next two years under two sponsored research agreements with biotechnology company United Therapeutics Corporation. The company focuses on developing novel pharmaceutical therapies and technologies that expand the availability of transplantable organs. Read more from News Medical Life Sciences.

646720login-checkJohns Hopkins Medicine surgeons to receive $21.4 million to advance xenotransplantation research
Loading

Deja una respuesta